FEB 20, 2019 06:30 PM PST

Silent Inflammation, the Silent Problem

People who have chronic inflammation in middle-age may develop problems with thinking and memory in the decades leading up to old age, according to a new study published in the February 13, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.

There are two kinds of inflammation. Acute inflammation happens when the body's immune response jumps into action to fight off infection or an injury. It is localized, short-term and part of a healthy immune system. Chronic inflammation is not considered healthy. It is a low-grade inflammation that lingers for months or even years throughout the body. It can be caused by autoimmune disorders like rheumatoid arthritis or multiple sclerosis, physical stress or other causes. Symptoms of chronic inflammation include joint pain or stiffness, digestive problems, and fatigue.

Ways to reduce chronic inflammation include getting regular exercise, following a heart-healthy anti-inflammatory diet, and getting enough sleep.

"Chronic inflammation is tough on the body, and can damage joints, internal organs, tissue, and cells," said study author Keenan A. Walker, Ph.D., of Johns Hopkins University in Baltimore, Md. "It can also lead to heart disease, stroke, and cancer. While other studies have looked at chronic inflammation and its effects on the brain in older people, our large study investigated chronic inflammation beginning in middle age and showed that it might contribute to cognitive decline in the decades leading up to old age."

As part of the Atherosclerosis Risk in Communities (ARIC) Study, researchers followed 12,336 people with an average age of 57 for approximately 20 years. Researchers took blood samples from participants at the start of the study, measuring four biomarkers of inflammation: fibrinogen, white blood cell count, von Willebrand factor, and factor VIII. They created a composite inflammation score for the four biomarkers. Three years later, researchers measured C-reactive protein, another blood biomarker of inflammation. Participants were divided into four groups based on their composite inflammation scores and C-reactive protein levels.

Participants' thinking and memory skills were tested at the beginning of the study, six to nine years later, and at the end of the study.

Researchers found the group with the highest levels of inflammation biomarkers had an 8-percent steeper decline in thinking and memory skills throughout the study than the group with the lowest levels of inflammation biomarkers. The group with the highest C-reactive protein levels had a 12-percent steeper decline in thinking and memory skills than the group with the lowest levels. These results were derived after researchers adjusted for other factors that could affect thinking and memory skills, such as education, heart disease, and high blood pressure. Further analyses revealed that inflammation-associated declines in thinking were most prominent in areas of memory, compared to other aspects of thinking such as language and executive functioning.

"Overall, the additional change in thinking and memory skills associated with chronic inflammation was modest, but it was greater than what has been seen previously associated with high blood pressure in middle age," Walker said.

"Many of the processes that can lead to a decline in thinking and memory skills are believed to begin in middle age, and it is in middle age that they may also be most responsive to intervention," said Walker. "Our results show that chronic inflammation may be an important target for intervention. However, it's also possible that chronic inflammation is not a cause and instead of a marker of, or even a response to, neurodegenerative brain diseases that can lead to cognitive decline."

A limitation of the study was that participants with higher levels of chronic inflammation at the start of the study were more likely to drop out or die before the final follow-up visit, so surviving participants may not be representative of the general population.

Future studies could include more frequent assessments of thinking and memory skills. They could also examine a more extensive variety of inflammation markers in the blood.

Sources: Science Daily, Neurology, YouTube

About the Author
You May Also Like
NOV 27, 2018
Immunology
NOV 27, 2018
A Genetic Switch During Inflammation
Microglia, CNS immune cells, change their genetic profile during different states of the inflammation spectrum...
DEC 15, 2018
Drug Discovery
DEC 15, 2018
Ebola-Fighting Protein Paves The Way For New Drugs
In a study published in Cell, research at Northwestern University School of Medicine has involved scientists discovering a human protein that could be...
JAN 23, 2019
Health & Medicine
JAN 23, 2019
Impact of Ankylosing Spondylitis on Quality of Life
  Ankylosing spondylitis (AS) is a chronic inflammatory disease that most often affects the sacroiliac (SI) joints and axial skeleton (see figure abov...
JAN 15, 2019
Immunology
JAN 15, 2019
Unconventional T Cells
Spondyloarthritis is one of the most common types of chronic joint inflammation affecting nearly 1-2 percent of the Western population. Scientists report that rare populations of unconvention...
JAN 30, 2019
Immunology
JAN 30, 2019
Targeting Transplant Rejection
Bone marrow from a donor contains healthy immune cells whose mission is to protect the body from invaders. Immune cells can target the recipient's cancer cells and offer protection....
FEB 12, 2019
Immunology
FEB 12, 2019
Why Does My Throat Hurt Again
Scientists are uncovering the mechanisms behind recurring cases of step throat...
Loading Comments...